ID: ALA3091631

Max Phase: Preclinical

Molecular Formula: C23H21NO5

Molecular Weight: 391.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(Cc2cccc(Oc3ccccc3)c2)c(CCC(=O)O)c(C=O)c1O

Standard InChI:  InChI=1S/C23H21NO5/c1-15-23(28)20(14-25)19(10-11-22(26)27)21(24-15)13-16-6-5-9-18(12-16)29-17-7-3-2-4-8-17/h2-9,12,14,28H,10-11,13H2,1H3,(H,26,27)

Standard InChI Key:  JFBRYAUUBAOZRW-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 391.42Molecular Weight (Monoisotopic): 391.1420AlogP: 4.31#Rotatable Bonds: 8
Polar Surface Area: 96.72Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.43CX Basic pKa: 4.10CX LogP: 3.68CX LogD: 1.10
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -0.02

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source